Amphastar Pharmaceuticals, Inc.· AMPH
🇺🇸 US · SmallSP600NASDAQ
- Price
- $19.90
- Day
- -1.58%
- Mkt Cap
- $877.45M
- 52W Range
- $16.65 – $31.26
- Volume
- 450.3K
- Beta
- 0.90
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
RANCHO CUCAMONGA, Calif., July 29, 2026 /PRNewswire/ -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that the Company will release results for its second quarter of 2026 ended June 30, 2026, after the market closes on Thursday, August 6, 2026, and will hold a conference call to discuss its financial results at 2:00 p.m.
Read full article
Trump plans tariffs of up to 200% on imported generic drugs after a two-year grace period aimed at encouraging U.S. manufacturing. But thin profit margins make tariffs harder to absorb than for branded medicines and and key policy details remain unclear.
Read full article